Y-Intercept (HK)’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-24,552
Closed -$130K 1671
2024
Q1
$130K Buy
24,552
+10,867
+79% +$57.7K 0.01% 1239
2023
Q4
$84.7K Buy
+13,685
New +$84.7K 0.01% 1120
2023
Q3
Sell
-26,258
Closed -$254K 1356
2023
Q2
$254K Buy
+26,258
New +$254K 0.03% 839